-
4-(4-Chloro-5-(2,5-dimethyl-7-(pentan-3-yl)pyrazolo[1,5-a]pyrimidin-3-yl)thiazol-2-yl)morpholine
-
BD015719421014983-00-698%
-
¥474.010mg
-
N-Butyl-N-ethyl-7-mesityl-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
-
BD01134165220953-69-597%
-
¥2344.025mg
-
2-(Mesityloxy)-3,6-dimethyl-N-(pentan-3-yl)pyridin-4-amine
-
BD00941388175140-00-898%
-
¥4865.0100mg
-
N-((R)-sec-Butyl)-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine
-
BD01121013459856-18-998%
-
¥918.05mg
-
2-(Mesityloxy)-3,6-dimethyl-4-(pentan-3-yloxy)pyridine
-
BD01126890175139-41-099+%
-
¥11730.05mg
-
5-Chloro-N4-(cyclopropylmethyl)-2-methyl-N4-propyl-N6-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine
-
BD01255627184241-44-998%
-
¥20306.0100mg
-
(R)-4-(2-Chloro-4-methoxy-5-methylphenyl)-N-(2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-N-(prop-2-yn-1-yl)thiazol-2-amine
-
BD022112332649012-21-398%
-
¥
-
Emicerfont
-
BD00780296786701-13-198%
-
¥119990.0100mg
-
CP-376395 hydrochloride
-
BD012126781013933-37-398%
-
¥9074.050mg
-
N-(4-Methoxy-2-methylphenyl)-1-(1-methoxybutan-2-yl)-6-methyl-1H-[1,2,3]triazolo[4,5-c]pyridin-4-amine
-
BD01152630197801-88-097%
-
¥
-
Nvs-crf38
-
BD6299931207258-55-699+%
-
¥6532.025mg
-
5-Chloro-N4-(cyclopropylmethyl)-2-methyl-N4-propyl-N6-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine hydrochloride
-
BD012717301215766-76-997%
-
¥
-
N-Butyl-N-ethyl-7-mesityl-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
-
BD672982157284-96-397%
-
¥
-
(S)-4-(1-cyclopropyl-2-methoxyethyl)-6-((6-(difluoromethoxy)-2,5-dimethylpyridin-3-yl)amino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile
-
BD011824631188407-45-5
-
¥
-
JTC-017
-
BD01849301357330-77-998%
-
¥
-
BMS-665053
-
BD011727351173435-64-795%
-
¥
-
(S)-3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-(1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl)pyrazolo[1,5-a]pyrimidin-7-amine
-
BD00787381885220-61-198%
-
¥6018.05mg